October 21, 2020
This phase 2 trial also identified a subset of patients with specific mutations who may see the most benefit from the drug. When first- and second-line treatments have been exhausted, few options remain for patients with advanced head and neck cancer. A new phase 2 clinical trial by researchers at […]
